MetaCap

Praxis Precision Medicines Cash Flow Statement

NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

259.86-3.69 (-1.40%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Praxis Precision Medicines free cash flow

In fiscal 2025, Praxis Precision Medicines generated -$249.1 million of operating cash flow and spent $56,000 on capital expenditures. That left free cash flow of -$249.1 million.

Summary generated from market data by MetaCap's automated system. Methodology

Praxis Precision Medicines cash flow statement (annual)

Praxis Precision Medicines annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31
Net Income-303.27M-182.82M-123.28M-214.03M-167.06M-61.82M-35.51M
Net Income growth (YoY)———————
Depreciation & Amortization140.00K358.00K432.00K419.00K182.00K50.00K37.00K
Stock-Based Compensation33.94M41.36M24.86M28.59M22.69M5.21M668.00K
Change in Working Capital23.94M12.04M-13.03M-1.03M16.94M3.93M1.40M
Operating Cash Flow-249.07M-131.76M-111.14M-185.04M-124.55M-52.62M-33.42M
Capital Expenditures-56.00K0-50.00K-444.00K-1.05M0-103.00K
Investing Cash Flow-311.15M-248.49M38.95M96.89M-140.52M0-103.00K
Financing Cash Flow702.17M514.32M91.87M10.46M107.59M304.42M60.39M
Net Change in Cash141.96M134.07M19.68M-77.69M-157.49M251.79M26.86M
Free Cash Flow-249.12M-131.76M-111.19M-185.49M-125.60M-52.62M-33.52M

This table shows 7 annual periods of Praxis Precision Medicines's cash flow statement, from FY 2025 back to FY 2019, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PRAX's reporting calendar. What is a cash flow statement?

More financial data